GAFFX
Price
$85.14
Change
+$0.99 (+1.18%)
Updated
Jul 31 closing price
Net Assets
356.86B
JDCRX
Price
$44.07
Change
+$0.90 (+2.08%)
Updated
Jul 31 closing price
Net Assets
23.8B
Interact to see
Advertisement

GAFFX vs JDCRX

GAFFX vs JDCRX Comparison Chart in %
View a ticker or compare two or three
VS
GAFFX vs. JDCRX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and JDCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 357B vs. JDCRX (23.8B). GAFFX pays higher dividends than JDCRX: GAFFX (0.53) vs JDCRX (0.00). GAFFX was incepted earlier than JDCRX: GAFFX (10 years) vs JDCRX (22 years). JDCRX (1.31) is less costly to investors than GAFFX (0.29). JDCRX (33.00) and GAFFX (32.00) have comparable annual turnover. JDCRX has a lower initial minimum investment than GAFFX: JDCRX (2500) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 1.95 vs. JDCRX (-10.77). GAFFX return over 5 years is better than : 15.04 vs. JDCRX (-13.42).
GAFFXJDCRXGAFFX / JDCRX
Total Expense Ratio0.291.3122%
Annual Report Gross Expense Ratio0.291.3122%
Fund Existence10 years22 years-
Gain YTD5.790-0.300-1,929%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets357B23.8B1,500%
Annual Yield % from dividends0.530.00-
Returns for 1 year1.95-10.77-18%
Returns for 3 years37.379.37399%
Returns for 5 years15.04-13.42-112%
Returns for 10 yearsN/A55.85-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDDIX9.59N/A
N/A
MassMutual Diversified Value I
FESGX82.31-0.03
-0.04%
First Eagle Global C
PPVIX13.37-0.03
-0.22%
Principal SmallCap Value II Instl
JIESX23.85-0.14
-0.58%
JPMorgan Developed International Value I
AZBIX29.38-0.18
-0.61%
Virtus Small-Cap Institutional